Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-66.73	96.47	-289.98
Graham Fair Price	273.47	3.26	0.87
PEG	-99.50	< 0.005	-0.59
Price/Book	43.43	0.47	0.33
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-92.97	3.81	54.25
Price/Sales	-5.12	3.97	4.18
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	148.43	-0.04	0.02
ROA	1469.19	< 0.005	< 0.005
ROE	< 0.005	0.03	1940.88
ROIC	< 0.005	< 0.005	148.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.55	-77.43
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.95	-4.08	-327.61
EPS QOQ	-0.91	12.89	1311.80
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.10	0.24	130.34
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.77	0.77	-0.15
Quick Ratio	0.59	-3.43	484.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.72	3.90	-17.33
Cash	14.88	-25.95	74.31
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	0.37	0.46	24.97
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.59	5.18	782.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-565.68	201.77	-64.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating